The reciprocal t(9;22) fusion proteins p40ABL/BCR and p96ABL/BCR are expressed in patient-derived Ph+ ALL and CML cells. This evidence concerns the gene BCR and chronic myelogenous leukemia, BCR-ABL1 positive.